{"DataElement":{"publicId":"3210431","version":"1","preferredName":"Phase Grouping Factor Type","preferredDefinition":"a subdivision related to a distinguishable part where the sampling units are separated into groups whereby no subject is exposed to more than one level._a subdivision the grouping factor by phase.","longName":"3015339v1.0:3210430v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3015339","version":"1","preferredName":"Phase Grouping Factor","preferredDefinition":"information related to a distinguishable part where the sampling units are separated into groups whereby no subject is exposed to more than one level.","longName":"2523472v1.0:3015337v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2523472","version":"1","preferredName":"Phase","preferredDefinition":"A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","longName":"C25257","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase","conceptCode":"C25257","definition":"A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E79036C-9C75-5B75-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-27","endDate":null,"createdBy":"UMLLOADER_DRUGSCREEN","dateCreated":"2006-09-27","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3015337","version":"1","preferredName":"Grouping Factor","preferredDefinition":"A factor whose levels separate the sampling units into groups whereby no subject is exposed to more than one level of the factor.","longName":"C61039","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grouping Factor","conceptCode":"C61039","definition":"A factor whose levels separate the sampling units into groups whereby no subject is exposed to more than one level of the factor.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"804D27D9-244E-EF36-E040-BB89AD430BD6","latestVersionIndicator":"Yes","beginDate":"2010-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-02-23","modifiedBy":"ONEDATA","dateModified":"2010-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"804D27D9-245F-EF36-E040-BB89AD430BD6","latestVersionIndicator":"Yes","beginDate":"2010-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-02-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3210430","version":"1","preferredName":"Phase Group Factor Type","preferredDefinition":"a subdivision of the grouping factor by phase.","longName":"3210430v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"45","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Phase III","valueDescription":"Phase III","ValueMeaning":{"publicId":"2569184","version":"1","preferredName":"Phase III","longName":"2569184","preferredDefinition":"Phase III Trial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DB4D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F40F621-6E66-E1E3-E040-BB89AD431EEA","beginDate":"2011-03-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-03-24","modifiedBy":"ONEDATA","dateModified":"2011-03-24","deletedIndicator":"No"},{"value":"Phase II","valueDescription":"Phase II","ValueMeaning":{"publicId":"2569183","version":"1","preferredName":"Phase II","longName":"2569183","preferredDefinition":"Phase II Trial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DB4C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F40F621-6E7B-E1E3-E040-BB89AD431EEA","beginDate":"2011-03-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-03-24","modifiedBy":"ONEDATA","dateModified":"2011-03-24","deletedIndicator":"No"},{"value":"Feasibility","valueDescription":"Feasibility","ValueMeaning":{"publicId":"3233719","version":"1","preferredName":"Feasibility","longName":"3233719","preferredDefinition":"Feasibility","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2878FC9-88F2-1238-E040-BB89AD4317B2","latestVersionIndicator":"Yes","beginDate":"2011-05-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2878FC9-890B-1238-E040-BB89AD4317B2","beginDate":"2011-05-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"Phase I","valueDescription":"Phase I","ValueMeaning":{"publicId":"2569181","version":"1","preferredName":"Phase I","longName":"2569181","preferredDefinition":"Phase I Trial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DB4A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2636B3A-9233-4A9F-E040-BB89AD4303A8","beginDate":"2011-05-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-05-03","modifiedBy":"ONEDATA","dateModified":"2011-05-03","deletedIndicator":"No"},{"value":"1","valueDescription":"Phase I","ValueMeaning":{"publicId":"2569181","version":"1","preferredName":"Phase I","longName":"2569181","preferredDefinition":"Phase I Trial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DB4A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A301586D-C8C4-04DD-E040-BB89AD4354D2","beginDate":"2011-05-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-05-11","modifiedBy":"ONEDATA","dateModified":"2011-05-11","deletedIndicator":"No"},{"value":"2","valueDescription":"Phase II","ValueMeaning":{"publicId":"2569183","version":"1","preferredName":"Phase II","longName":"2569183","preferredDefinition":"Phase II Trial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DB4C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A301586D-C8D9-04DD-E040-BB89AD4354D2","beginDate":"2011-05-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-05-11","modifiedBy":"ONEDATA","dateModified":"2011-05-11","deletedIndicator":"No"},{"value":"Double blind randomization","valueDescription":"Double Blind Study Randomization Phase","ValueMeaning":{"publicId":"4993871","version":"1","preferredName":"Double Blind Study Randomization Phase","longName":"4993871","preferredDefinition":"A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. (MSH2001): The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.: A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Double Blind Study","conceptCode":"C15228","definition":"A study method in which neither the subjects nor the investigators are permitted to know which subject is receiving which treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Randomization","conceptCode":"C25196","definition":"The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Phase","conceptCode":"C25257","definition":"A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EA62887-0B9A-AC3C-E050-BB89AD433BC3","latestVersionIndicator":"Yes","beginDate":"2015-08-31","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-08-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1EA62887-0BB3-AC3C-E050-BB89AD433BC3","beginDate":"2015-08-31","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-08-31","modifiedBy":"ONEDATA","dateModified":"2015-08-31","deletedIndicator":"No"},{"value":"Early safety assessment","valueDescription":"Early Safety Assessment Phase","ValueMeaning":{"publicId":"4993872","version":"1","preferredName":"Early Safety Assessment Phase","longName":"4993872","preferredDefinition":"At or near the beginning of a period of time or course of events.: The state of being certain that adverse effects will not be caused by some agent under defined conditions.: The final result of a determination of the value, significance, or extent of.: A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Early","conceptCode":"C61589","definition":"At or near the beginning of a period of time or course of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Safety","conceptCode":"C60828","definition":"The state of being certain that adverse effects will not be caused by some agent under defined conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Phase","conceptCode":"C25257","definition":"A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EA62887-0BC2-AC3C-E050-BB89AD433BC3","latestVersionIndicator":"Yes","beginDate":"2015-08-31","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-08-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1EA62887-0BDB-AC3C-E050-BB89AD433BC3","beginDate":"2015-08-31","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-08-31","modifiedBy":"ONEDATA","dateModified":"2015-08-31","deletedIndicator":"No"},{"value":"Phase II post update #3","valueDescription":"Phase II Trial Post Update Number Three","ValueMeaning":{"publicId":"6224713","version":"1","preferredName":"Phase II Trial Post Update Number Three","longName":"6224713","preferredDefinition":"A study to test whether a new treatment has an anticancer effect (for example, whether it shrinks a tumor or improves blood test results) and whether it works against a certain type of cancer.: Happening at a time subsequent to a reference time; later in time or order.: Make current; supply with recent information or technology.: A numeral or string of numerals expressing value, quantity, or identification. : A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase II Trial","conceptCode":"C15601","definition":"A clinical research protocol designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Update","conceptCode":"C25710","definition":"Make current; supply with recent information or technology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A350840-9149-5972-E053-F662850A3838","latestVersionIndicator":"Yes","beginDate":"2018-04-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-04-19","modifiedBy":"ONEDATA","dateModified":"2018-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A350840-9162-5972-E053-F662850A3838","beginDate":"2018-04-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-04-19","modifiedBy":"ONEDATA","dateModified":"2018-04-19","deletedIndicator":"No"},{"value":"Safety run-in","valueDescription":"Safety Run-in Period","ValueMeaning":{"publicId":"6847954","version":"1","preferredName":"Safety Run-in Period","longName":"6847954","preferredDefinition":"The state of being certain that adverse effects will not be caused by some agent under defined conditions.: A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or evaluated for any other protocol-specified reason.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Safety","conceptCode":"C60828","definition":"The state of being certain that adverse effects will not be caused by some agent under defined conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Run-in Period","conceptCode":"C98779","definition":"A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or evaluated for any other protocol-specified reason.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F86F95A-8D84-5C68-E053-F662850A1E7B","latestVersionIndicator":"Yes","beginDate":"2019-08-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-07","modifiedBy":"ONEDATA","dateModified":"2019-08-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F86F95A-8D9D-5C68-E053-F662850A1E7B","beginDate":"2019-08-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-07","modifiedBy":"ONEDATA","dateModified":"2019-08-07","deletedIndicator":"No"},{"value":"Post safety run-in","valueDescription":"Post Safety Run-in Period","ValueMeaning":{"publicId":"6847953","version":"1","preferredName":"Post Safety Run-in Period","longName":"6847953","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.: The state of being certain that adverse effects will not be caused by some agent under defined conditions.: A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or evaluated for any other protocol-specified reason.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Safety","conceptCode":"C60828","definition":"The state of being certain that adverse effects will not be caused by some agent under defined conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Run-in Period","conceptCode":"C98779","definition":"A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or evaluated for any other protocol-specified reason.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F86F95A-8D5E-5C68-E053-F662850A1E7B","latestVersionIndicator":"Yes","beginDate":"2019-08-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-07","modifiedBy":"ONEDATA","dateModified":"2019-08-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F86F95A-8D77-5C68-E053-F662850A1E7B","beginDate":"2019-08-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-07","modifiedBy":"ONEDATA","dateModified":"2019-08-07","deletedIndicator":"No"},{"value":"PK Substudy (Dose finding portion)","valueDescription":"PK Substudy (Dose finding portion)","ValueMeaning":{"publicId":"7413099","version":"1","preferredName":"PK Substudy (Dose finding portion)","longName":"7413099","preferredDefinition":"PK Substudy (Dose finding portion)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AECF628F-96E0-5F73-E053-4EBD850AFC80","latestVersionIndicator":"Yes","beginDate":"2020-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-09-08","modifiedBy":"ONEDATA","dateModified":"2020-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AECF628F-96F9-5F73-E053-4EBD850AFC80","beginDate":"2020-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-09-08","modifiedBy":"ONEDATA","dateModified":"2020-09-08","deletedIndicator":"No"},{"value":"Non-Surgical","valueDescription":"Non-Surgical","ValueMeaning":{"publicId":"7516517","version":"1","preferredName":"Non-Surgical","longName":"7516517","preferredDefinition":"Not pertaining to or amenable to surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Surgical","conceptCode":"C25591","definition":"Not pertaining to or amenable to surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5556CE3-7C72-2879-E053-4EBD850AD27F","latestVersionIndicator":"Yes","beginDate":"2020-11-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-11-30","modifiedBy":"ONEDATA","dateModified":"2020-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5556CE3-7C8B-2879-E053-4EBD850AD27F","beginDate":"2020-11-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-11-30","modifiedBy":"ONEDATA","dateModified":"2020-11-30","deletedIndicator":"No"},{"value":"Surgical","valueDescription":"Surgical Procedure","ValueMeaning":{"publicId":"5630031","version":"1","preferredName":"Surgical Procedure","longName":"5630031","preferredDefinition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4675F8CB-DBA7-7809-E053-F662850AD243","latestVersionIndicator":"Yes","beginDate":"2017-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5556CE3-7C95-2879-E053-4EBD850AD27F","beginDate":"2020-11-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-11-30","modifiedBy":"ONEDATA","dateModified":"2020-11-30","deletedIndicator":"No"},{"value":"Phase II expansion, age greater than 60 years","valueDescription":"Phase II expansion, age greater than 60 years","ValueMeaning":{"publicId":"7652761","version":"1","preferredName":"Phase II expansion, age greater than 60 years","longName":"7652761","preferredDefinition":"Phase II expansion, age greater than 60 years","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8866-685D-79B3-E053-4EBD850AFC0D","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1FA8866-6876-79B3-E053-4EBD850AFC0D","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Phase II expansion, age less than or equal to 60 years","valueDescription":"Phase II expansion, age less than or equal to 60 years","ValueMeaning":{"publicId":"7652762","version":"1","preferredName":"Phase II expansion, age less than or equal to 60 years","longName":"7652762","preferredDefinition":"Phase II expansion, age less than or equal to 60 years","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8866-6880-79B3-E053-4EBD850AFC0D","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1FA8866-6899-79B3-E053-4EBD850AFC0D","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Phase II safety check, age greater than 60 years","valueDescription":"Phase II safety check, age greater than 60 years","ValueMeaning":{"publicId":"7652763","version":"1","preferredName":"Phase II safety check, age greater than 60 years","longName":"7652763","preferredDefinition":"Phase II safety check, age greater than 60 years","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8866-68A3-79B3-E053-4EBD850AFC0D","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1FA8866-68BC-79B3-E053-4EBD850AFC0D","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Phase II safety check, age less than or equal to 60 years","valueDescription":"Phase II safety check, age less than or equal to 60 years","ValueMeaning":{"publicId":"7652764","version":"1","preferredName":"Phase II safety check, age less than or equal to 60 years","longName":"7652764","preferredDefinition":"Phase II safety check, age less than or equal to 60 years","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8866-68C6-79B3-E053-4EBD850AFC0D","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1FA8866-68DF-79B3-E053-4EBD850AFC0D","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Safety lead-in, age greater than 60 years","valueDescription":"Safety lead-in, age greater than 60 years","ValueMeaning":{"publicId":"7652765","version":"1","preferredName":"Safety lead-in, age greater than 60 years","longName":"7652765","preferredDefinition":"Safety lead-in, age greater than 60 years","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8866-68E9-79B3-E053-4EBD850AFC0D","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1FA8866-6902-79B3-E053-4EBD850AFC0D","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Safety lead-in, age less than or equal to 60 years","valueDescription":"Safety lead-in, age less than or equal to 60 years","ValueMeaning":{"publicId":"7652766","version":"1","preferredName":"Safety lead-in, age less than or equal to 60 years","longName":"7652766","preferredDefinition":"Safety lead-in, age less than or equal to 60 years","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8866-690C-79B3-E053-4EBD850AFC0D","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1FA8866-6925-79B3-E053-4EBD850AFC0D","beginDate":"2021-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Non-Resectable","valueDescription":"Unresectable","ValueMeaning":{"publicId":"2964842","version":"1","preferredName":"Unresectable","longName":"2964842","preferredDefinition":"Unable to be removed with surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unresectable","conceptCode":"C14151","definition":"Not capable of being removed by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A02CEF7-C9D2-C96C-E040-BB89AD430150","latestVersionIndicator":"Yes","beginDate":"2009-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE14DB18-7D9B-71CA-E053-4EBD850AD442","beginDate":"2021-10-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-10-11","modifiedBy":"ONEDATA","dateModified":"2021-10-11","deletedIndicator":"No"},{"value":"Resectable","valueDescription":"Resectable","ValueMeaning":{"publicId":"7797519","version":"1","preferredName":"Resectable","longName":"7797519","preferredDefinition":"Capable of being removed by surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Resectable","conceptCode":"C25653","definition":"Capable of being removed by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE14DB18-7DA6-71CA-E053-4EBD850AD442","latestVersionIndicator":"Yes","beginDate":"2021-10-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-10-11","modifiedBy":"ONEDATA","dateModified":"2021-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE14DB18-7DBF-71CA-E053-4EBD850AD442","beginDate":"2021-10-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-10-11","modifiedBy":"ONEDATA","dateModified":"2021-10-11","deletedIndicator":"No"},{"value":"Safety Lead-in","valueDescription":null,"ValueMeaning":{"publicId":"11069987","version":"1","preferredName":"Safety Lead","longName":"11069987v1.00","preferredDefinition":"The state of being certain that adverse effects will not be caused by some agent under defined conditions._Be in charge of; a position of leadership.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Safety","conceptCode":"C60828","definition":"The state of being certain that adverse effects will not be caused by some agent under defined conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lead","conceptCode":"C25552","definition":"Be in charge of; a position of leadership.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5FBD7BB-F0F3-760A-E053-731AD00A7603","latestVersionIndicator":"Yes","beginDate":"2022-08-11","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-08-11","modifiedBy":"CLOHNES","dateModified":"2022-08-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5FBD7BB-F0F4-760A-E053-731AD00A7603","beginDate":"2022-08-11","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-08-11","modifiedBy":"CLOHNES","dateModified":"2022-08-11","deletedIndicator":"No"},{"value":"Early Phase (Group 1: Regimen 200mg GM1)","valueDescription":null,"ValueMeaning":{"publicId":"11097584","version":"1","preferredName":"Early Phase (Group 1: Regimen 200mg GM1)","longName":"11097584v1.00","preferredDefinition":"Early Phase (Group 1: Regimen 200mg GM1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60EEFF7-FB73-5470-E053-731AD00AE85E","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-08-12","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E60EEFF7-FB75-5470-E053-731AD00AE85E","beginDate":"2022-08-12","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-08-12","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","deletedIndicator":"No"},{"value":"Early Phase (Group 2: Regimen 400mg GM1)","valueDescription":null,"ValueMeaning":{"publicId":"11097585","version":"1","preferredName":"Early Phase (Group 2: Regimen 400mg GM1)","longName":"11097585v1.00","preferredDefinition":"Early Phase (Group 2: Regimen 400mg GM1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60EEFF7-FB74-5470-E053-731AD00AE85E","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-08-12","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E60EEFF7-FB76-5470-E053-731AD00AE85E","beginDate":"2022-08-12","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-08-12","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008529","version":"1","preferredName":"Research Protocols","preferredDefinition":"the identification of cancer research protocols.","longName":"RSCH_PROT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECC2BE-2F27-348A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F40F621-6E46-E1E3-E040-BB89AD431EEA","latestVersionIndicator":"Yes","beginDate":"2011-03-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-03-24","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/2022: added two PVs for Alliance per ticket#0001415wz;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"3015339v1.0:3210430v1.0","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Cohort","type":"Preferred Question Text","description":"Cohort","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Grouping Factor","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Group","url":null,"context":"Alliance"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Phase of Accrual","url":null,"context":"Alliance"},{"name":"Alliance - 1","type":"Alternate Question Text","description":"Study Component:","url":null,"context":"Alliance"},{"name":"CRF text4","type":"Alternate Question Text","description":"Phase","url":null,"context":"Alliance"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F40F621-6E86-E1E3-E040-BB89AD431EEA","latestVersionIndicator":"Yes","beginDate":"2011-03-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-03-24","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/11/22 added AQT for Alliance CJL;8/12/2022: added AQT for Alliance.wz","unresolvedIssues":null,"deletedIndicator":"No"}}